Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5286943
Max Phase: Preclinical
Molecular Formula: C58H68IN5O2
Molecular Weight: 867.22
Associated Items:
ID: ALA5286943
Max Phase: Preclinical
Molecular Formula: C58H68IN5O2
Molecular Weight: 867.22
Associated Items:
Canonical SMILES: C[N+]1=C(/C=C/C=C/C=C/C=C2/N(CCCCCC(=O)Nc3ccc4ccn(CCCCN5CCC6(CC5)OCc5ccccc56)c4c3)c3ccccc3C2(C)C)C(C)(C)c2ccccc21.[I-]
Standard InChI: InChI=1S/C58H67N5O2.HI/c1-56(2)48-24-15-17-26-50(48)60(5)53(56)28-10-7-6-8-11-29-54-57(3,4)49-25-16-18-27-51(49)63(54)38-19-9-12-30-55(64)59-46-32-31-44-33-39-62(52(44)42-46)37-21-20-36-61-40-34-58(35-41-61)47-23-14-13-22-45(47)43-65-58;/h6-8,10-11,13-18,22-29,31-33,39,42H,9,12,19-21,30,34-38,40-41,43H2,1-5H3;1H
Standard InChI Key: XRKOGBPJCJGXIG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 867.22 | Molecular Weight (Monoisotopic): 866.5368 | AlogP: 12.50 | #Rotatable Bonds: 16 |
Polar Surface Area: 52.75 | Molecular Species: BASE | HBA: 5 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.80 | CX Basic pKa: 9.48 | CX LogP: 8.69 | CX LogD: 6.62 |
Aromatic Rings: 5 | Heavy Atoms: 65 | QED Weighted: 0.06 | Np Likeness Score: -0.48 |
1. Abatematteo FS, Majellaro M, Montsch B, Prieto-Díaz R, Niso M, Contino M, Stefanachi A, Riganti C, Mangiatordi GF, Delre P, Heffeter P, Sotelo E, Abate C.. (2023) Development of Fluorescent 4-[4-(3H-Spiro[isobenzofuran-1,4'-piperidin]-1'-yl)butyl]indolyl Derivatives as High-Affinity Probes to Enable the Study of σ Receptors via Fluorescence-Based Techniques., 66 (6): [PMID:36919956] [10.1021/acs.jmedchem.2c01227] |
Source(1):